Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Opinion: Focus on preclinical sex differences will not address women's and men's health disparities.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Multiple sclerosis review.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
The 10th European Congress of Neuropathology
Use of rituximab in multiple sclerosis: current progress and future perspectives.
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Pattern of remyelination in the CNS.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
Daclizumab in multiple sclerosis: a high-yield extension study.
Clinical proteomics of enervated neurons.
UCSF Seminar: "How do we get a myelinated brain? A new model for distribution of oligodendrocytes throughout the developing CNS"

Pages